Trevor Ostlund

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Chemical biology & drug design

Drug development research

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Felix Acheampong, Trevor Ostlund, Mater Mahnashi, Fathi Halaweish
Estrone analogs as potential inhibitors targeting EGFR-MAPK pathway in non-small-cell lung cancer. Chemical biology & drug design (2023)
Felix Acheampong, Trevor Ostlund, Mater Mahnashi, Fathi Halaweish
Antiproliferation and apoptosis studies of estrone pharmacophores in triple-negative breast cancer. Chemical biology & drug design (2023)
Felix Acheampong, Trevor Ostlund, Mater Mahnashi, Fathi Halaweish
Estrone Analogs as Potential Inhibitors Targeting EGFR-MAPK Pathway in Non-Small Cell Lung Cancer. Chemical biology & drug design (2023)
Mathias T Anim, Isaac Tuffour, Rylan Willis, Matthew Schell, Trevor Ostlund, Mater H Mahnashi, Fathi Halaweish, Rachel Willand-Charnley
Deacetylated Sialic Acid Sensitizes Lung and Colon Cancers to Novel Cucurbitacin-Inspired Estrone Epidermal Growth Factor Receptor (EGFR) Inhibitor Analogs. Molecules (Basel, Switzerland) 28 (17) (2023)
Trevor Ostlund, Kakan SutraDhar, Sara M Elgazwi, Mater Mahnashi, Jennifer Kyeremateng, Surtaj Iram, Fathi Halaweish
Novel EGFR-MAPK kinase and ABC transporter inhibitors for HepG2 resistant to Erlotinib. Drug development research (2022)